enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hemopump - Wikipedia

   en.wikipedia.org/wiki/Hemopump

   The pump was first used on 25 April 1988 in a 61 years old man, a recent heart transplant recipient who was in the midst of a profound acute episode of rejection and cardiogenic shock. The pump successfully sustained him for 46 hours while there had been sufficient recovery of myocardial contractility to redraw the Hemopump support. [5]

3. Ventricular assist device - Wikipedia

   en.wikipedia.org/wiki/Ventricular_assist_device

   The study is to assess the system as bridge-to-transplantation for patients with end-stage heart failure. The study, Evaluation of the HeartWare LVAD System for the Treatment of Advanced Heart Failure, is a multi-center study that started in May 2009. [38] [39]

4. Protected percutaneous coronary intervention - Wikipedia

   en.wikipedia.org/wiki/Protected_percutaneous...

   During a protected percutaneous coronary intervention (Protected PCI) procedure, "the Impella 2.5 heart pump helps maintain a stable heart function by pumping blood for the heart. This gives a weak heart muscle an opportunity to rest and reduces the heart’s workload, preventing the heart from being overstressed by the procedure as coronary ...

5. Impella - Wikipedia

   en.wikipedia.org/wiki/Impella

   Impella heart pumps are percutaneous microaxial pumps that act as mechanical circulatory support devices in patients in need of hemodynamic support. [11] The pumps are mounted on support catheters and typically inserted through the femoral artery , although axillary and subclavian artery approaches are not uncommon.

6. Are you neglecting your 'second heart'? 1 step to ... - AOL

   www.aol.com/news/neglecting-second-heart-1-step...

   The heart gets an assist from another pump in blood circulation. Called the "second heart," it only starts pumping when legs move. Are you neglecting your 'second heart'? 1 step to activate it now

7. Cardiac contractility modulation - Wikipedia

   en.wikipedia.org/wiki/Cardiac_contractility...

   The FDA approved the OPTIMIZER Smart System, which delivers cardiac contractility modulation therapy, as indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for cardiac resynchronization therapy, and ...